Harvard Women's Health Watch

What's the story with Fosamax?

Research suggests that the osteoporosis medication Fosamax, if taken for a long period of time, could cause a change in bones that makes them more susceptible to fracture. But the studies in question are inconclusive, so more research is necessary.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In